Protagonist Therapeutics, Inc
Develops peptide therapeutics for blood disorders and inflammatory or immunomodulatory diseases.
PTGX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74366E1029
- LEI:
- Country:
- United States of America
- Address:
- 7707 GATEWAY BLVD., SUITE 140, NEWARK
- Website:
- https://www.protagonist-inc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop peptide-based therapeutics. The company specializes in creating new chemical entities to address unmet medical needs. Its development pipeline is focused on treatments for hematology and blood disorders, as well as inflammatory and immunomodulatory diseases, including gastrointestinal conditions such as ulcerative colitis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Protagonist Therapeutics, Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Protagonist Therapeutics, Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Protagonist Therapeutics, Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
